Metyrapone (Synonyms: NSC 25265, SU 4885) |
Catalog No.GC17411 |
11-β hydroxylase (CYP11B1) inhibitor
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 54-36-4
Sample solution is provided at 25 µL, 10mM.
Metyrapone is an inhibitor of cytochrome P450-mediated ω/ω-1 hydroxylase activity and CYP11B1.Target: CYP11B1Metyrapone is a drug used in the diagnosis of adrenal insufficiency and occasionally in the treatment of Cushing's syndrome (hypercortisolism). Metyrapone blocks cortisol synthesis by reversibly inhibiting steroid 11β-hydroxylase. This stimulates ACTH secretion, which in turn increases plasma 11-Deoxycortisol levels.
Average Rating: 5
(Based on Reviews and 29 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *